SPRC Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

0.810

Open

0.810

VWAP

1.00

Vol

296.00K

Mkt Cap

3.00M

Low

0.752

Amount

232.00K

EV/EBITDA(TTM)

--

Total Shares

4.00M

EV

5.00M

EV/OCF(TTM)

--

P/S(TTM)

--

Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Show More

Events Timeline

(ET)

2026-01-26

08:20:00

SciSparc Completes Acquisition of Xylo's IP Portfolio

2026-01-13 (ET)

2026-01-13

07:10:00

SciSparc Acquires Patent Portfolio from Xylo Technologies

2026-01-12 (ET)

2026-01-12

16:10:00

SciSparc Notified by Nasdaq of Non-Compliance with Listing Requirements

2025-12-30 (ET)

2025-12-30

08:40:00

SciSparc's NeuroThera Labs Secures Patent from Israel

2025-12-02 (ET)

2025-12-02

09:40:00

SciSparc Acquires 55% Stake in NeuroThera from Quantum Bio Data Firm

2025-12-01 (ET)

2025-12-01

08:50:00

SciSparc Acquires 19.99% Stake in Xylo's Patent Portfolio for Innovative Medical Systems

2025-11-26 (ET)

2025-11-26

07:45:31

SciSparc to Obtain Patent Portfolio for Medical Endoscopy Technologies

2025-11-20 (ET)

2025-11-20

06:46:29

SciSparc and Clearmind Medicine Submit Patent Application in Israel for Depression Treatment

2025-11-17 (ET)

2025-11-17

07:59:26

Clearmind Medicine Secures Israeli Patent for Depression Therapy

2025-10-30 (ET)

2025-10-30

09:26:47

N2OFF Finalizes Merger with MitoCareX Bio

News

an image of NASDAQ.COM

01-16NASDAQ.COM

Sanofi Secures EU Approval for Teizeild, Demonstrating Significant Efficacy in Type 1 Diabetes

an image of Benzinga

SciSparc Ltd. Acquires Endoscopy Patents, Shares Drop 12.07%

an image of seekingalpha

01-13seekingalpha

SciSparc (SPRC) Faces Nasdaq Compliance Risk Due to Negative Equity

an image of Globenewswire

2025-12-30Globenewswire

SciSparc Secures Israeli Patent Enhancing Opioid Efficacy

an image of Newsfilter

2025-12-30Newsfilter

SciSparc Secures Israeli Patent Enhancing Opioid Efficacy

an image of Benzinga

2025-12-05Benzinga

Ulta Beauty Stock Rises Approximately 6%; Check Out 20 Stocks Making Moves in Premarket Trading

Valuation Metrics

The current forward P/E ratio for Scisparc Ltd (SPRC.O) is 0.00, compared to its 5-year average forward P/E of -11.36. For a more detailed relative valuation and DCF analysis to assess Scisparc Ltd 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

an image of dotted line Image

N/A

5Y Average PE

-11.36

Current PE

0.00

Overvalued PE

26.06

Undervalued PE

-48.78

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

an image of dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

an image of dotted line Image

N/A

5Y Average PS

1.42

Current PS

0.19

Overvalued PS

4.48

Undervalued PS

-1.63

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

Find stocks with low float

Intellectia · 2888 candidates

Region: USShares Outstanding: <= 150,000,000

Ticker

Name

Market Cap$

Aditxt Inc

3.00M

Greenwave Technology Solutions Inc

4.00M

Golden Heaven Group Holdings Ltd

5.00M

American Rebel Holdings Inc

3.00M

iPower Inc

6.00M

UTime Ltd

1.00M

3 stocks with RSI below 25

Intellectia · 221 candidates

Rsi Category: oversold

Ticker

Name

Market Cap$

Wix.Com Ltd

4.00B

Volato Group Inc

4.00M

Outlook Therapeutics Inc

32.00M

Jet.AI Inc

5.00M

Scisparc Ltd

5.00M

iPower Inc

6.00M

Whales Holding SPRC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Scisparc Ltd (SPRC) stock price today?

The current price of SPRC is 0.79 USD — it has decreased -5.39 % in the last trading day.

What is Scisparc Ltd (SPRC)'s business?

Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

What is the price predicton of SPRC Stock?

Wall Street analysts forecast SPRC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SPRC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Scisparc Ltd (SPRC)'s revenue for the last quarter?

Scisparc Ltd revenue for the last quarter amounts to 78.00 USD, decreased % YoY.

What is Scisparc Ltd (SPRC)'s earnings per share (EPS) for the last quarter?

Scisparc Ltd. EPS for the last quarter amounts to USD, decreased % YoY.

How many employees does Scisparc Ltd (SPRC). have?

Scisparc Ltd (SPRC) has 2 emplpoyees as of January 30 2026.

What is Scisparc Ltd (SPRC) market cap?

Today SPRC has the market capitalization of 3.00M USD.